Annual report pursuant to Section 13 and 15(d)

Significant Customers Concentrations - Narrative (Details)

v3.24.1
Significant Customers Concentrations - Narrative (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Concentration Risk [Line Items]    
Revenues, net $ 44,384 $ 122,647
Diagnostic Services    
Concentration Risk [Line Items]    
Revenues, net $ 24,849 $ 108,329
Revenue Benchmark | Segment Concentration Risk | Diagnostic Services    
Concentration Risk [Line Items]    
Concentration risk 54.90% 88.30%
Government Agencies | Revenue Benchmark | Customer Concentration Risk    
Concentration Risk [Line Items]    
Concentration risk 17.00% 29.00%
Insurance Providers | Revenue Benchmark | Customer Concentration Risk    
Concentration Risk [Line Items]    
Concentration risk 83.00% 66.00%
Client Payers | Revenue Benchmark | Customer Concentration Risk    
Concentration Risk [Line Items]    
Concentration risk   5.00%
Diagnostic Services Clients One | Reimbursement Receivable | Customer Concentration Risk    
Concentration Risk [Line Items]    
Concentration risk 32.60% 68.80%
Diagnostic Services Clients Two | Reimbursement Receivable | Customer Concentration Risk    
Concentration Risk [Line Items]    
Concentration risk 18.70% 16.00%
Diagnostic Services Clients Three | Reimbursement Receivable | Customer Concentration Risk    
Concentration Risk [Line Items]    
Concentration risk 12.60%